Page 4 - Kiran Mazumdar-shaw

Kiran Mazumdar-Shaw: Will take Covid vaccine; confident on safety, efficacy

Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates

HCL Tech's Roshni Nadar tops the list of India's wealthiest women

Kotak Wealth Hurun-Leading Wealthy Women features eight dollar billionaires and 38 women with wealth of Rs 1,000 crore and above

Hopefully DCGI to give nod for Oxford's vaccine immediately: Biocon chief

India saw 37,975 new coronavirus infections in a day taking the country's Covid-19 caseload to 91.77 lakh

Transparency critical in coronavirus vaccine trials: Kiran Mazumdar-Shaw

She says, after healthcare workers, the military, the police and anyone who is on the frontlines, teachers and the young working class, should be given the vaccines

India needs to scale up Covid-19 testing to contain pandemic: Mazumdar-Shaw

She said some parts of the country are dealing with testing in a better way than other parts of the country but as a whole, it is not at optimal levels and certainly, way below other countries

Forbes India Rich List 2020: Ambani dominance continues; see full list

With a global health crisis raging, listed pharma entrepreneurs fared well while those with interests in real estate suffered

Entrepreneurship is about having a purpose, says Kiran Majumdar Shaw

Entrepreneurship is not about making money but about having a purpose, renowned businesswoman Kiran Mazumdar-Shaw told Delhi government school students on Wednesday

Covid-19: We need a shift to sustainability, says Kiran Majumdar-Shaw

The pandemic has thrown us into the deep end in terms of using technology, and that is a positive development, says Shaw

IT services to remain significant to India's job environment: TCS CEO

He added that this is on account of the demand for talent and services, which is "only going to explode given the role that technology is playing today and in future"

Biocon-Mylan launch insulin Glargine at lowest price in US market

The commercialisation in the US of the drug, which already has approval in 45 countries, gives a boost to Biocon's ambitious target of $1 billion in sales through its biologics division by FY22

Biocon chairperson Kiran Mazumdar-Shaw tests positive for Covid-19

Shaw adds to the list of high-profile people who have been tested positive in Bengaluru in a span of few weeks, including Karnataka chief minister B S Yediyurappa

Infosys independent director Bobby Parikh fined for stock market trade

Parikh was appointed as an Independent Director of Infosys effective July 15, 2020, based on the recommendations of the Nomination and Remuneration Committee of the Board

Self-reliance to determine how high flag of freedom flies, says India Inc

Welcoming the National Digital Health Mission, Biocon CMD Kiran Mazumdar Shaw said it gives India's healthcare sector a digital backbone

Russia isn't world's first to develop Covid-19 vaccine: Kiran Mazumdar-Shaw

"If launching a vaccine prior to completion of Phase 3 trials is acceptable to Russia, well so be it," Mazumdar-Shaw said

Itolizumab to be a blockbuster opportunity for Biocon: Kiran Mazumdar-Shaw

We felt that this was the drug that would actually have a role to play in dealing with the cytokine storm that is being seen in Covid-19 patients, says Shaw

Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%

High R&D spend, low profitability in research services due to Covid-19 pull down net profit

Cheer in Covid times

Here's the backstory of Biocon's Alzumab which has been approved by the CDSCO for the treatment of Covid-19 in India

Biocon's Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020

Shaw was picked from among 46 award winners from 41 countries and territories vying for the global title

Biocon MD Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year

The Biocon MD was picked from among 46 nominations from 41 countries

Vaccine for Covid-19 will take long time to be ready: Kiran Mazumdar-Shaw

The quickest for any vaccine to be prepared is not less than four years, says Kiran Mazumdar-Shaw.